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We thank Cynthia Goldsmith and 
colleagues for their interest in our 
recent Correspondence.1 We described 
autopsy findings from patients who 
had died from COVID-19 and showed 
a systemic endotheliitis with evidence 
of loss of integrity of the endothelial 
monolayer.1
The framework of endotheliitis 
provides an explanation for the unique 
predilection of severe acute respiratory 
syndrome coronavirus 2 (SARS-CoV-2) 
in those in dividuals with hypertension, 
diabetes, or established cardiovas-
cular disease, a group known to have 
pre-existing endothelial dysfunction. 
COVID-19-endotheliitis could also 
explain impaired microcirculatory 
function across different organs and 
the frequently observed prothrombotic 
state with in-situ clot formation. 
Endothelial infection and injury by 
SARS-CoV-1 has been shown.2 Our 
demonstration of viral particles using 
electron microscopy (EM) is supported 
by several reports independently 
describing ultrastructural round 
virus-like particles in the setting of a 
SARS-CoV-2 infection.3–6 We demon-
strated tubulo-reticular structures in 
the immediate vicinity of the spherical 
particles that are strikingly identical 
to SARS-CoV-1-associated membrane 
changes described by Goldsmith and 
colleagues in 2004.7 In our EM thin-
section images, the virus-like particles 
were relatively large (mean diameter 
180 nm [SD 10]). How ever, subsequent 
analysis of more EM images has revealed 
a mean particle size of 67 nm (SD 15 nm, 
median 65 nm, 95% CI 41–102; n=33). 
Zhu and colleagues5 noted that 
SARS-CoV-2 virions ranged from “about 
60 to 140 nm”. In another recent study,6 
virus-like particles in patients with 
confirmed SARS-CoV-2 infection were 
70–110 nm in diameter. By comparison, 
SARS-CoV-1 viral particles analysed 
with the same technique (ultrathin EM 
imaging) were 50–80 nm in diameter.7–10
Goldsmith and colleagues have 
studied coronavirus isolates grown in 
cell culture, whereas our EM data of 
virus-like particles were obtained from a 
post-mortem kidney allograft obtained 
during autopsy. Since most other recent 
reports of patients with COVID-19 
also describe post mortem findings, 
it remains unclear to what extent 
tissue type (cell culture, fresh biopsy 
material, or autopsy material), time to 
fixation, and post mortal autolysis alter 
subcellular structures in preparation 
for EM. This notwithstanding, these 
observed particles in patients with 
COVID-19 should be best designated 
as virus-like particles because definitive 
assign ment of these structures as SARS-
CoV-2 virions requires immuno-EM.
Investigations with vascular 
organoids that preceded our obser-
vations1 showed that SARS-CoV-2 can 
infect human blood vessels via the 
ACE2 pathways, providing the first 
and direct evidence that the virus can 
indeed invade human vasculature.11 
Our findings have also been con-
firmed in descriptions of renal tropism 
of SARS-CoV-2, with detection 
of SARS-CoV-2 protein in human 
glomerular endothelial and epithelial 
cells.12
Importantly, our demonstration 
of virus cell infection in the kidney 
and endotheliitis1 points to a general 
host inflammatory response causing 
hyperinflammation as a principal 
participant in the vascular pathology of 
COVID-19. Endothelial cell dysfunction, 
which might subsequently induce 
a prothrombotic state, could thus 
explain the vascular microcirculatory 
complications seen in different organs 
in patients with COVID-19.
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